novel
seri
isoxazolidin
substitut
variou
quinazolinon
synthes
cycloaddit
nmethylc
diethoxyphosphoryl
nitron
isoxazolidin
assess
antivir
activ
broad
rang
dna
rna
virus
isoxazolidin
show
weak
activ
ec
toward
vzv
tk
strain
one
order
magnitud
lower
acyclovir
use
refer
drug
phosphon
appear
slightli
activ
toward
cytomegaloviru
ec
compound
contain
benzyl
substitu
quinazolinon
skeleton
exhibit
slight
antiprolif
activ
toward
test
immort
cell
ic
rang
nitrogencontain
heterocycl
form
core
natur
product
eg
alkaloid
also
present
mani
pharmacophor
well
numer
market
drug
among
quinazolin
quinazolinon
drawn
special
attent
due
broad
spectrum
biolog
activ
deriv
includ
sed
anticanc
antivir
antibacteri
antifung
antiinflamatori
antifibrot
activ
sever
review
focus
synthet
strategi
biolog
activ
compound
publish
signific
impact
variou
function
group
instal
quinazolinequinazolinon
framework
pharmacolog
properti
proven
last
decad
sever
compound
contain
framework
exhibit
promis
anticanc
well
antivir
properti
obtain
figur
furthermor
biolog
activ
substitut
one
isol
variou
fungi
bacteria
speci
exampl
one
found
entomopathogen
fungu
isaria
farinosa
strong
inhibitori
properti
replic
tobacco
mosaic
viru
tmv
recognis
wherea
analogu
present
fungu
penicillium
genu
appear
slightli
activ
toward
tmv
moreov
compound
exhibit
signific
cytotox
toward
variou
cancer
cell
line
quinazolinon
isol
streptomyc
sp
appear
cytotox
vero
cell
recent
synthet
pyridinecontain
analogu
deriv
obtain
slight
activ
influenza
viru
reveal
hand
variou
one
includ
compound
found
possess
antitumor
activ
slight
activ
influenza
viru
reveal
hand
variou
one
includ
compound
found
possess
antitumor
activ
continu
studi
antivir
cytostat
activ
isoxazolidin
analogu
cnucleosid
analogu
design
new
seri
compound
gener
formula
contain
substitut
quinazolinon
moieti
fals
nucleobas
isoxazolidin
ring
diethoxyphosphoryl
function
attach
synthet
strategi
compound
reli
cycloaddit
nmethylc
diethoxyphosphoryl
nitron
substitut
scheme
scheme
retrosynthesi
isoxazolidinyl
phosphon
modifi
substitut
benzyl
group
synthes
commerci
avail
acyl
chlorid
follow
cycliz
dehydrohalogen
prepar
key
intermedi
subsequ
reaction
substitut
benzyl
bromid
scheme
moreov
compound
r
r
et
also
obtain
intent
determin
influenc
benzyl
substitu
biolog
activ
design
isoxazolidin
hnmr
spectra
compound
characterist
signal
vinyl
proton
observ
ppm
three
doublet
doublet
continu
studi
antivir
cytostat
activ
isoxazolidin
analogu
cnucleosid
analogu
design
new
seri
compound
gener
formula
contain
substitut
quinazolinon
moieti
fals
nucleobas
isoxazolidin
ring
diethoxyphosphoryl
function
attach
synthet
strategi
compound
reli
cycloaddit
nmethylc
diethoxyphosphoryl
nitron
substitut
scheme
slight
activ
influenza
viru
reveal
hand
variou
one
includ
compound
found
possess
antitumor
activ
continu
studi
antivir
cytostat
activ
isoxazolidin
analogu
cnucleosid
analogu
design
new
seri
compound
gener
formula
contain
substitut
quinazolinon
moieti
fals
nucleobas
isoxazolidin
ring
diethoxyphosphoryl
function
attach
synthet
strategi
compound
reli
cycloaddit
nmethylc
diethoxyphosphoryl
nitron
substitut
scheme
scheme
retrosynthesi
isoxazolidinyl
phosphon
modifi
substitut
benzyl
group
synthes
commerci
avail
acyl
chlorid
follow
cycliz
dehydrohalogen
prepar
key
intermedi
subsequ
reaction
substitut
benzyl
bromid
scheme
moreov
compound
r
r
et
also
obtain
intent
determin
influenc
benzyl
substitu
biolog
activ
design
isoxazolidin
hnmr
spectra
compound
characterist
signal
vinyl
proton
observ
ppm
three
doublet
doublet
scheme
retrosynthesi
isoxazolidinyl
phosphon
modifi
substitut
benzyl
group
synthes
commerci
avail
acyl
chlorid
follow
cycliz
dehydrohalogen
prepar
key
intermedi
subsequ
reaction
substitut
benzyl
bromid
scheme
moreov
compound
r
r
et
also
obtain
intent
determin
influenc
benzyl
substitu
biolog
activ
design
isoxazolidin
hnmr
spectra
compound
characterist
signal
vinyl
proton
observ
ppm
three
doublet
doublet
cycloaddit
nitron
led
format
diastereoisomer
mixtur
isoxazolidin
good
diastereoselect
scheme
tabl
ratio
cistran
diastereoisom
calcul
pnmr
spectra
crude
reaction
mixtur
confirm
analysi
hnmr
spectral
data
crude
mixtur
isoxazolidin
cycloadduct
subject
purif
silica
gel
column
howev
attempt
isol
pure
diastereoisom
fruit
rel
configur
isoxazolidin
establish
base
previou
studi
stereochemistri
cycloaddit
nmethylc
diethoxyphosphoryl
nitron
variou
vinyl
aryl
sinc
similar
hnmr
spectral
patter
respect
seri
transand
cisisoxazolidin
observ
sinc
compound
necessari
coupl
constant
success
extract
hand
cnmr
spectra
detail
conform
analysi
perform
base
data
j
hz
j
hz
j
hz
cycloaddit
nitron
led
format
diastereoisomer
mixtur
isoxazolidin
good
diastereoselect
scheme
tabl
ratio
cistran
diastereoisom
calcul
pnmr
spectra
crude
reaction
mixtur
confirm
analysi
hnmr
spectral
data
crude
mixtur
isoxazolidin
cycloadduct
subject
purif
silica
gel
column
howev
attempt
isol
pure
diastereoisom
fruit
r
h
r
c
h
ch
r
h
ch
r
h
ch
r
tabl
ratio
cistran
diastereoisom
calcul
pnmr
spectra
crude
reaction
mixtur
confirm
analysi
hnmr
spectral
data
crude
mixtur
isoxazolidin
cycloadduct
subject
purif
silica
gel
column
howev
attempt
isol
pure
diastereoisom
fruit
r
h
r
r
r
r
rel
configur
isoxazolidin
establish
base
previou
studi
stereochemistri
cycloaddit
nmethylc
diethoxyphosphoryl
nitron
variou
vinyl
aryl
sinc
similar
hnmr
spectral
patter
respect
seri
transand
cisisoxazolidin
observ
sinc
compound
necessari
coupl
constant
success
extract
hand
cnmr
spectra
detail
conform
analysi
perform
base
data
j
hz
j
hz
j
hz
scheme
synthesi
isoxazolidin
reaction
condit
toluen
h
rel
configur
isoxazolidin
establish
base
previou
studi
stereochemistri
cycloaddit
nmethylc
diethoxyphosphoryl
nitron
variou
vinyl
aryl
sinc
similar
hnmr
spectral
patter
respect
seri
transand
cisisoxazolidin
observ
sinc
compound
necessari
coupl
constant
success
extract
hand
cnmr
spectra
detail
conform
analysi
perform
base
data
j
hz
j
hz
j
hz
j
hz
j
hz
j
hz
j
cccp
hz
reveal
isoxazolidin
ring
adopt
e
conform
diethoxyphosphoryl
group
resid
equatori
posit
isoxazolidin
ring
quinazolinon
substitu
locat
pseudoequatori
figur
hand
ci
configur
minor
isom
establish
correspond
coupl
j
hz
j
hz
j
hz
j
hz
j
hz
j
hz
j
cccp
hz
indic
e
conform
isoxazolidin
ring
figur
addit
argument
support
assign
follow
shield
ch
ch
op
proton
observ
ci
isom
ca
ppm
compar
furthermor
found
hnmr
spectrum
taken
mixtur
cisand
hn
proton
quinazolinon
ring
significantli
deshield
ppm
compar
tran
isom
highli
like
result
hydrogen
bond
format
phosphoryl
oxygen
amid
phenomenon
spatial
achiev
ci
isom
sinc
introduct
variou
substitu
quinazolinon
moieti
influenc
stereochem
outcom
cycloaddit
therefor
configur
major
isoxazolidin
assign
tran
therebi
minor
one
ci
figur
addit
argument
support
assign
follow
shield
proton
observ
ci
isom
ca
ppm
compar
furthermor
found
hnmr
spectrum
taken
mixtur
cisand
hn
proton
quinazolinon
ring
significantli
deshield
ppm
compar
tran
isom
highli
like
result
hydrogen
bond
format
phosphoryl
oxygen
amid
phenomenon
spatial
achiev
ci
isom
sinc
introduct
variou
substitu
quinazolinon
moieti
influenc
stereochem
outcom
cycloaddit
therefor
configur
major
isoxazolidin
assign
tran
therebi
minor
one
ci
ganciclovir
cidofovir
acyclovir
brivudin
zalcitabin
zanamivir
alovudin
amantadin
rimantadin
ribavirin
dextran
sulfat
molecular
weight
mycophenol
acid
hippeastrum
hybrid
agglutinin
hha
urtica
dioica
agglutinin
uda
use
refer
compound
antivir
activ
express
compound
concentr
requir
reduc
viru
plaqu
format
vzv
reduc
virusinduc
cytopathogen
virus
sever
isoxazolidin
abl
weakli
inhibit
replic
tk
tk
vzv
strain
valu
rang
tabl
among
phosphon
ganciclovir
cidofovir
acyclovir
brivudin
zalcitabin
zanamivir
alovudin
amantadin
rimantadin
ribavirin
dextran
sulfat
molecular
weight
mycophenol
acid
hippeastrum
hybrid
agglutinin
hha
urtica
dioica
agglutinin
uda
use
refer
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
viru
plaqu
format
vzv
reduc
virusinduc
cytopathogen
virus
sever
isoxazolidin
abl
weakli
inhibit
replic
tk
tkv
zv
strain
ec
valu
rang
tabl
among
phosphon
r
h
ch
ec
r
h
ch
ec
r
h
ch
ec
activ
toward
tk
vzv
oka
strain
exhibit
activ
toward
strain
activ
isoxazolidin
tk
vzv
oka
strain
lower
refer
drug
acyclovir
hand
ec
valu
strain
acyclovir
resist
strain
phosphon
r
c
h
ch
ec
r
et
ec
compar
acyclovir
ec
deriv
show
similar
ec
tk
strain
therefor
potenc
tk
vzv
approxim
lower
compar
acyclovir
furthermor
compound
r
c
h
ch
r
c
h
ch
r
c
h
ch
r
h
ch
show
activ
human
cytomegaloviru
ec
although
less
activ
ganciclovir
cidofovir
use
refer
compound
tabl
none
phosphon
deriv
describ
show
activ
test
dna
rna
virus
cytostat
inhibitori
concentr
ic
caus
decreas
cell
prolifer
determin
murin
leukemia
human
lymphocyt
cem
human
cervix
carcinoma
hela
immort
human
dermal
microvacsular
endotheli
cell
isoxazolidin
r
h
r
inhibit
cell
prolifer
highest
test
concentr
ie
wherea
r
et
appear
slightli
cytostat
toward
test
cell
line
ic
hand
tabl
entri
b
compound
benzyl
substitu
quinazolinon
moieti
show
lower
ic
valu
ic
therebi
indic
instal
function
benzyl
group
profit
inhibitori
properti
tabl
inhibitori
effect
test
compound
prolifer
murin
leukemia
human
tlymphocyt
cem
human
cervix
carcinoma
hela
immort
human
dermal
microvascular
endotheli
cell
solut
mmol
acetonitril
ml
potassium
carbon
mmol
ad
min
respect
benzyl
bromid
mmol
ad
reaction
mixtur
stir
reflux
h
solvent
remov
residu
extract
water
ml
organ
layer
dri
mgso
concentr
crude
product
purifi
silica
gel
column
methylen
chlorid
hexan
mixtur
vv
follow
crystallis
chloroformpetroleum
ether
give
pure
quinazolinon
nch
anal
calcd
c
solut
mmol
acetonitril
ml
potassium
carbon
mmol
ad
min
iodomethan
mmol
iodoethan
mmol
ad
reaction
mixtur
stir
h
solvent
remov
residu
extract
water
ml
organ
layer
dri
mgso
concentr
crude
product
purifi
silica
gel
column
methylen
chlorid
hexan
mixtur
vv
follow
crystal
chloroform
petroleum
ether
give
pure
quinazolinon
one
amorph
solid
mp
refer
mp
solut
nitron
mmol
respect
vinyl
quinazolinon
mmol
toluen
ml
stir
disappear
tlc
start
nitron
volatil
remov
vacuo
crude
product
subject
chromatographi
silica
gel
column
chloroformmethanol
vv
mixtur
eluent
diethyl
tran
phosphon
yellowish
oil
ir
film
max
diethyl
tran
phosphon
data
note
correspond
mixtur
yellowish
oil
ir
film
max
